Media & Resources

Filter by

Type
- All types
- Fact Sheets & Publications
- Features
- IAVI Report
- In The News
- Podcasts
- Press Releases
- Scientific Publications
- Vaccine Literacy Library
- Videos
Health area
- Clinical trials(2)
- COVID-19(60)
- Ebola Sudan(40)
- EID(2)
- Emerging infectious diseases(1)
- Global access(13)
- HIV(409)
- Lassa fever(41)
- Lassa virus(1)
- Malaria(1)
- Marburg(18)
- Marburg virus(1)
- Other(103)
- Sexually transmitted infections(1)
- Snakebite(6)
- Sudan virus(9)
- TB(1)
- Tuberculosis(82)
- Vaccine research(19)
Location
- Africa(251)
- Europe(34)
- Global(475)
- India(17)
- Japan(1)
- United States(27)
- US(4)
- USA(3)
- Washington(1)
Topic
- Access(19)
- Antibodies(92)
- Capacity strengthening(13)
- Clinical trials(117)
- Community engagement(43)
- Emerging infectious diseases(1)
- Epidemiology(43)
- Funding(46)
- Germline targeting(5)
- Global access(8)
- Key populations(8)
- Pandemic preparedness(31)
- Partnerships(41)
- People(61)
- Policy and advocacy(47)
- Regulatory pathways(6)
- Social-behavioral research(3)
- Vaccine research(255)
Year
Journal
- Acta Crystallogr. D Biol. Crystallogr.(1)
- Addict Behav Rep(1)
- Afr J Lab Med(1)
- AIDS(41)
- AIDS Behav(10)
- AIDS Behav.(1)
- AIDS Care(5)
- AIDS Patient Care STDS(1)
- AIDS Res Hum Retroviruses(25)
- AIDS Res Ther(1)
- Am J Mens Health(1)
- Am J Public Health(1)
- Anal. Biochem.(1)
- Angew. Chem. Int. Ed. Engl.(2)
- Ann. Hum. Genet.(1)
- Ann. Intern. Med.(1)
- Ann. N. Y. Acad. Sci.(1)
- Ann. Oncol.(1)
- Annu. Rev. Immunol.(1)
- Annu. Rev. Med.(1)
- Biochemistry(3)
- Biologicals(3)
- Biomolecules(1)
- Biores Open Access(1)
- bioRxiv(1)
- Biotechnol Bioeng(2)
- Biotechnol J(1)
- Blood(1)
- BMC Biochem.(1)
- BMC Global Public Health(1)
- BMC Health Serv Res(2)
- BMC Immunol.(1)
- BMC Infect Dis(6)
- BMC Infect Dis.(1)
- BMC Med(2)
- BMC Med Educ(1)
- BMC Med Res Methodol(1)
- BMC Public Health(7)
- BMC Res Notes(1)
- BMC Womens Health(2)
- BMJ Glob Health(1)
- BMJ Open(2)
- Br. Med. Bull.(1)
- Bull. World Health Organ.(1)
- Campbell Syst Rev(1)
- Cell(10)
- Cell Chem Biol(1)
- Cell Host Microbe(2)
- Cell Rep(15)
- Chem Asian J(1)
- Chem. Biol.(1)
- Chem. Commun. (Camb.)(1)
- Clin Infect Dis(4)
- Clin. Vaccine Immunol.(3)
- Cogent Med(1)
- Contemp Clin Trials Commun(1)
- Contraception(3)
- Cult Health Sex(1)
- Curr Opin HIV AIDS(5)
- Curr. HIV Res.(1)
- Curr. Opin. Biotechnol.(1)
- Curr. Opin. Immunol.(3)
- Curr. Opin. Mol. Ther.(1)
- Curr. Opin. Struct. Biol.(1)
- Curr. Pharm. Des.(1)
- Curr. Top. Microbiol. Immunol.(1)
- Current Opinion in HIV and AIDS(1)
- East Afr Med J(2)
- eBioMedicine(3)
- Elife(1)
- Epidemiol. Infect.(1)
- Epidemiology(1)
- Eur. J. Immunol.(2)
- Expert Rev Vaccines(7)
- FASEB J.(1)
- Front Cell Infect Microbiol(1)
- Front Immunol(14)
- Front Microbiol(2)
- Front Public Health(1)
- Front Reprod Health(2)
- Gates Open Res(1)
- Gene Ther.(1)
- Genes Immun.(3)
- Global Health(1)
- Glycobiology(3)
- Health Aff (Millwood)(2)
- Health Policy(1)
- Health Promot Int(1)
- Health Res Policy Syst(1)
- HIV Med(1)
- Hum Vaccin(2)
- Hum Vaccin Immunother(2)
- Hum. Genet.(1)
- Human Vaccines & Immunotherapeutics(1)
- IJID Reg(1)
- Immunity(30)
- Immunol. Rev.(4)
- Indian J Pediatr(2)
- Indian J. Med. Res.(4)
- Int Health(3)
- Int J Epidemiol(2)
- Int J Med Inform(2)
- Int J STD AIDS(4)
- J Adv Manuf Process(1)
- J Antimicrob Chemother(1)
- J Comput Chem(1)
- J Exp Med(1)
- J Family Med Prim Care(1)
- J HIV AIDS Surveill Epidemiol(1)
- J Immunol(16)
- J Infect Dis(16)
- J Int AIDS Soc(14)
- J Pharm Sci(2)
- J Womens Health (Larchmt)(1)
- J. Acquir. Immune Defic. Syndr.(16)
- J. Am. Chem. Soc.(3)
- J. Am. Soc. Mass Spectrom.(1)
- J. Biol. Chem.(9)
- J. Clin. Invest.(2)
- J. Clin. Microbiol.(1)
- J. Exp. Med.(11)
- J. Gen. Virol.(11)
- J. Hepatol.(1)
- J. Immunol. Methods(9)
- J. Med. Primatol.(1)
- J. Mol. Biol.(6)
- J. Pept. Sci.(1)
- J. Virol.(115)
- J. Virol. Methods(2)
- JCI Insight(1)
- JMIR Res Protoc(1)
- Lancet(12)
- Lancet Glob Health(1)
- Lancet HIV(3)
- Lancet Infect Dis(3)
- lancet microbe(2)
- Lancet Respir Med(1)
- mBio(4)
- medRxiv(1)
- Methods Mol. Med.(1)
- Microbiol Spectr(2)
- Microorganisms(1)
- Mol Ther Methods Clin Dev(1)
- Mol. Ther.(3)
- Mucosal Immunol(1)
- N. Engl. J. Med.(7)
- Nat Commun(18)
- Nat Immunol(2)
- Nat Med(15)
- Nat Microbiol(2)
- Nat. Biotechnol.(1)
- Nat. Chem. Biol.(1)
- Nat. Immunol.(5)
- Nat. Rev. Immunol.(1)
- Nat. Rev. Microbiol.(1)
- Nat. Struct. Mol. Biol.(4)
- Nature(20)
- NEJM(1)
- npj Vaccines(3)
- Nucleic Acids Res.(1)
- Open Forum Infect Dis(2)
- Org. Biomol. Chem.(1)
- Orphanet J Rare Dis.(1)
- Pan Afr Med J(3)
- PDA J Pharm Sci Technol(1)
- Pharmaceut Med(1)
- Pharmacoeconomics(2)
- PLoS Glob Public Health(7)
- PLoS Med.(5)
- PLoS Negl Trop Dis(1)
- PLoS One(86)
- PLoS Pathog(36)
- Proc Natl Acad Sci U S A(32)
- Proteins(1)
- Proteomics(2)
- Rapid Commun. Mass Spectrom.(1)
- Res Involv Engagem(1)
- Retrovirology(13)
- Rev. Med. Virol.(1)
- S. Afr. Med. J.(1)
- Sci Adv(2)
- Sci Immunol(5)
- Sci Rep(8)
- Sci Transl Med(11)
- Science(38)
- Sex Health(1)
- Sex Transm Dis(4)
- Sex Transm Infect(12)
- Southeast Asian J. Trop. Med. Public Health(1)
- Springerplus(1)
- Structure(4)
- Stud Fam Plann(1)
- Syst Rev(1)
- Ther Adv Vaccines(1)
- Top HIV Med(1)
- Toxins(1)
- Trends Microbiol.(1)
- Trends Parasitol(1)
- Trop Dis Travel Med Vaccines(1)
- Trop. Med. Int. Health(7)
- Vaccine(33)
- Vaccines (Basel)(3)
- Virology(36)
- Viruses(1)
- Wellcome Open Res(1)
- Women's Health (Lond)(1)
Publication
- AARP(1)
- ABC 10 News in San Diego,(1)
- ABC News(1)
- ABCNEWS(1)
- AFP News(1)
- AIDSmap(1)
- ANI(1)
- Apna Radio 96.9 fm(1)
- AVAC(1)
- BBC(1)
- BioSpace,(1)
- BioWorld,(1)
- Bloomberg(4)
- Bloomberg Businessweek(1)
- BNN Bloomberg(1)
- Business Daily(1)
- Business Insider(2)
- Center for Global Development(1)
- CEPI(2)
- CGTN(1)
- Chemical & Engineering News(1)
- CIDRAP(4)
- Clinical Trials Arena(2)
- CNBC(1)
- CNN(4)
- CNN International(1)
- Contagion Live(1)
- Cope,(1)
- CSIS(1)
- CSIS Global Health Policy Center(1)
- Daily Mail(1)
- Daily Maverick(1)
- Daily Nation(2)
- Devex(7)
- Drug Discovery & Development,(1)
- Ebru TV (video)(1)
- Economic Times(1)
- El Confidencial(1)
- El Español,(1)
- El Global,(1)
- El País(2)
- EndPoints News(1)
- Es Radio Albacete,(1)
- ETHealthWorld (video)(1)
- EU Observer(1)
- European Commission(1)
- Fierce Pharma,(1)
- Financial Times(1)
- Fox News,(1)
- Gates Foundation(1)
- Gavi(7)
- GEN,(1)
- GeneOnline(1)
- Genetic Engineering & Biotechnology News(1)
- Global Health NOW(1)
- Global Health Technologies Coalition(1)
- HCP Live,(1)
- Health Affairs,(1)
- Health Analytics Asia(1)
- Health Policy Watch(2)
- Hutch News Service(1)
- Indian Express(2)
- Inside Precision Medicine(1)
- International Business Times,(1)
- International Development Research Centre(1)
- La Razón(1)
- La Razón,(1)
- La Tribuna de Albacete(1)
- La Voz de Galicia(1)
- Le Monde(1)
- Los Angeles Times(2)
- Managed Healthcare Executive(2)
- Medical New Today(1)
- MedPage Today(1)
- Memorias(1)
- mosaic(1)
- Nasdaq,(1)
- National Geographic(1)
- National Review(1)
- Nature(6)
- Nature Biotechnology(1)
- Nature India(1)
- NBC News(1)
- New Scientist(1)
- News 18 India(1)
- Newsweek(1)
- NIAID(1)
- Nigeria Health Watch(3)
- Nigerian Television Authority(1)
- NPR(1)
- NPR Goats & Soda(1)
- NPR Goats and Soda(1)
- Person Place Thing (podcast)(1)
- PharmaVoice(1)
- Pindula(1)
- Politico(1)
- Popular Science(1)
- Positively Aware(1)
- Posterity Media(1)
- POZ(2)
- Precision Vaccinations,(1)
- ProPatiens(1)
- ProPatients(2)
- Pulse Nigeria(1)
- Refinery 29(1)
- Results UK(1)
- Reuters(2)
- Reuters,(1)
- Rolling Stone(1)
- Salon(2)
- Sayansi Magazine(1)
- SciDevNet,(2)
- Science(9)
- ScienceNews(1)
- Scroll.in(1)
- Spotlight(1)
- Standard(1)
- STAT(7)
- STAT News(13)
- STAT Plus (Subscription Required)(2)
- TechCrunch,(1)
- Telecinco,(2)
- The Advocate(1)
- The Associated Press(1)
- The BMJ(1)
- The Conversation(1)
- The Daily Nation(2)
- The Guardian(2)
- The Guardian Nigeria(2)
- The HILL(3)
- The Indian Express(1)
- THE LANCET(4)
- The New Times(1)
- The New York Times(3)
- The Observer(1)
- The Philadelphia Inquirer(1)
- The Standard(1)
- The Star(1)
- The Telegraph(4)
- The Voice of America(1)
- The Wall Street Journal(1)
- The Washington Post(2)
- The Wire(2)
- them.(1)
- TIDES Global(1)
- Times of India(2)
- USAID Blog(1)
- Vaccine Insights(1)
- VaccinesToday(1)
- VICE(1)
- Wall Street Journal,(1)
- WebMD(1)
- Weill Cornell(1)
- WIRED(1)
- World Health Organization(2)
- World Pharmaceutical Frontiers(1)
- Yale School of Medicine(1)
- Zendal(1)
Fact sheet & publication type
- Annual Reports(7)
- Community Engagement Resources(15)
- Fact Sheets(12)
- Policy and Advocacy Publications(23)
Keyword search
Clear all

Scientific Publications

Mapping the antibody response to Lassa virus vaccination of non-human primates

Scientific Publications

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial

Press Releases

IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa

October 10, 2025

Partners will advance end-to-end development of biologics for regionally prioritized diseases starting with Mpox and HIV

Advancing a sustainable supply and demand ecosystem for monoclonal antibodies in Africa

On April 6, 2025, Africa CDC and IAVI, with support from Wellcome and Unitaid, convened a high-level meeting in Abu Dhabi to chart a pathway for advancing a sustainable mAb ecosystem in Africa. The consensus was clear: Africa has the opportunity and capacity to leapfrog and lead in mAbs innovation and production.

In The News

Enhancing Lassa Fever Medical Countermeasures in West Africa

Nigeria Health Watch

September 24, 2025

In The News

Voices From #ELFIC2025 | Dr. Mark Feinberg, President & CEO, International AIDS Vaccine Initiative

Nigeria Health Watch

September 18, 2025

In The News

CHOP’s Vaccine Education Center experts fear policy changes coming under RFK’s health leadership

The Philadelphia Inquirer

September 18, 2025

About IAVI’s Lassa virus vaccine program

IAVI and our partners are developing a single-dose vaccine candidate for protection against Lassa virus (LASV). No vaccine is yet approved to prevent Lassa fever, the illness caused by LASV.

1…5 678 9…246 of 246

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

Mapping the antibody response to Lassa virus vaccination of non-human primates

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial

IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa

Advancing a sustainable supply and demand ecosystem for monoclonal antibodies in Africa

Enhancing Lassa Fever Medical Countermeasures in West Africa

Voices From #ELFIC2025 | Dr. Mark Feinberg, President & CEO, International AIDS Vaccine Initiative

CHOP’s Vaccine Education Center experts fear policy changes coming under RFK’s health leadership

About IAVI’s Lassa virus vaccine program

Subscription Type